Express Seed company to exclusively license poinsettia portfolio from Syngenta Flowers

Express Seed Company has obtained an exclusive license to Syngenta Flowers' Poinsettia portfolio, and the two companies are working closely together to ensure reliable supply and a smooth transfer of all activities.

Scott Valentine, Express Seed Company CEO, is looking forward to taking the lead on licensing, production, and future development of this product line. "Since Syngenta's announcement in July, we knew we wanted to step up and help our growers to secure reliable, quality cuttings for these well-known and respected varieties. Our technical support, product development, logistics capabilities, and strong relationships with global production partners are well-matched to ensure uninterrupted supply for our growers in 2023 and beyond."

For the North American market, production will remain at Vivero Internacional S.A. de C.V. Vivero's strict protocols will continue to ensure a high-quality, reliable cutting supply. Express will license the varieties for sale in all other global markets.

The existing team of sales, product, and technical experts at Express will launch the pipeline of varieties already developed by Syngenta. They will consult with Steve Rinehart for additional expertise on growing and meeting growers' expectations on new varieties. Valentine said, "We are thrilled to have access to Steve Rinehart as a consultant; his 40 years of experience in the poinsettia market will help our team be successful."

Syngenta's orders for unrooted cuttings in 2023 are expected to be transferred to Express Seed Company. Express will maintain existing agreements for sales of unrooted cuttings in the United States. In Canada, Express Seed Company will exclusively sell unrooted cuttings. Liners in both markets will be available from existing producers.

For more information:
Express Seed

Syngenta Flowers        


Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.